Literature DB >> 21791190

Benzalkonium chloride in glaucoma medications.

Robert Noecker1, Kimberly V Miller.   

Abstract

Benzalkonium chloride (BAK) is the preservative used most commonly in eye drops. Although it is effective as an antimicrobial and antifungal agent, both in vitro and in vivo studies have demonstrated adverse effects on surface epithelial cell populations. This is of particular concern with regard to topical medications used over long periods for chronic conditions, such as glaucoma. Newer non-BAK-containing drops are becoming increasingly available, providing an alternative for patients needing long-term eye drop therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21791190     DOI: 10.1016/s1542-0124(11)70025-8

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  11 in total

1.  Trans-conjunctival aqueous humor outflow in glaucomatous patients treated with prostaglandin analogues: an in vivo confocal microscopy study.

Authors:  Rodolfo Mastropasqua; Vincenzo Fasanella; Emilio Pedrotti; Manuela Lanzini; Silvio Di Staso; Leonardo Mastropasqua; Luca Agnifili
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-28       Impact factor: 3.117

2.  Effects of Detergent-Based Protocols on Decellularization of Corneas With Sclerocorneal Limbus. Evaluation of Regional Differences.

Authors:  Miguel González-Andrades; Victor Carriel; Mario Rivera-Izquierdo; Ingrid Garzón; Elena González-Andrades; Santiago Medialdea; Miguel Alaminos; Antonio Campos
Journal:  Transl Vis Sci Technol       Date:  2015-04-10       Impact factor: 3.283

3.  Efficacy of preservative-free tafluprost in patients with normal-tension glaucoma previously treated with latanoprost.

Authors:  Matteo Sacchi; Edoardo Villani; Paolo Nucci
Journal:  Clin Ophthalmol       Date:  2014-09-15

Review 4.  Medical Management of Glaucoma in the 21st Century from a Canadian Perspective.

Authors:  Paul Harasymowycz; Catherine Birt; Patrick Gooi; Lisa Heckler; Cindy Hutnik; Delan Jinapriya; Lesya Shuba; David Yan; Radmila Day
Journal:  J Ophthalmol       Date:  2016-11-08       Impact factor: 1.909

5.  Plant-derived angiogenin fusion protein's cytoprotective effect on trabecular meshwork damage induced by Benzalkonium chloride in mice.

Authors:  Jae Hoon Jeong; Soo Jin Lee; Kisung Ko; Jeong Hwan Lee; Jungmook Lyu; Moon Hyang Park; Jaeku Kang; Jae Chan Kim
Journal:  PeerJ       Date:  2020-05-22       Impact factor: 2.984

6.  Safety and Tolerability of an Eye Drop Based on 0.6% Povidone-Iodine Nanoemulsion in Dry Eye Patients.

Authors:  Giovanni William Oliverio; Rosaria Spinella; Elisa Imelde Postorino; Leandro Inferrera; Emanuela Aragona; Pasquale Aragona
Journal:  J Ocul Pharmacol Ther       Date:  2020-12-23       Impact factor: 2.671

Review 7.  Managing adverse effects of glaucoma medications.

Authors:  Kenji Inoue
Journal:  Clin Ophthalmol       Date:  2014-05-12

8.  Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose-response phenomenon.

Authors:  Jie Shen; Marina Bejanian
Journal:  Clin Ophthalmol       Date:  2016-03-03

9.  The ocular surface after successful glaucoma filtration surgery: a clinical, in vivo confocal microscopy, and immune-cytology study.

Authors:  Luca Agnifili; Lorenza Brescia; Francesco Oddone; Matteo Sacchi; Erminia D'Ugo; Guido Di Marzio; Fabiana Perna; Ciro Costagliola; Rodolfo Mastropasqua
Journal:  Sci Rep       Date:  2019-08-05       Impact factor: 4.379

10.  Combined iStent® Inject Trabecular Micro-Bypass and Phacoemulsification in Australian Patients with Open-Angle Glaucoma.

Authors:  Alon M Salby; Simon E Skalicky
Journal:  Clin Ophthalmol       Date:  2020-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.